Phosphodiesterase type 5 inhibitors for lower urinary tract symptoms associated with benign prostatic hyperplasia

Shih Tsung Huang*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Phosphodiesterase type 5 inhibitors for lower urinary tract symptoms associated with benign prostatic hyperplasia'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science